The University of Chicago Header Logo

Connection

Lynne Kaminer to Maintenance Chemotherapy

This is a "connection" page, showing publications Lynne Kaminer has written about Maintenance Chemotherapy.
Connection Strength

0.201
  1. Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial. Leuk Res. 2021 12; 111:106736.
    View in: PubMed
    Score: 0.201
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.